• Submissions to VMOA shall be made through the journal web page (http://veterinariamexico.fmvz.unam.mx/index.php/vet). Manuscripts sent by e-mail are not accepted. Users must create an Author account before they are able to submit a manuscript. For that purpose, first-time users are invited to register for free by accessing the “Register” link on the journal’s web page. The system will prompt a registration form and authors are requested to indicate whether they are willing to participate as reviewers for the journal (leave this field blank if not willing to act as a reviewer). After registration is completed, the system will open a new page where authors can start a new submission.
  • Carefully review VMOA’s scope and editorial policies. Make sure your manuscript complies with both. Otherwise, your submission may be declined or its editorial process will be delayed. The easiest way to ensure compliance with style, format, and editorial policies is by using VMOA’s manuscript template.

The text shall be double-spaced and left-justify across the whole document, including references and figure legends.

  • Use 12-point Arial font, US letter (8.5 x 11”) page portrait layout, and the same margins of 2.5 cm (top/bottom/left/right).
  • Number pages and lines (continuous line numbering).
  • Make sure statistical treatment of data, if applicable, is properly described in the methods section.
  • For research articles, authors must include a "Study Contribution" section providing a nontechnical explanation that captures the importance of the study and its contribution to its field of knowledge. Refer to VMOA’s manuscript templatefor examples.
  • Authors are required to make all experimental data fully available to readers. Thus, submissions shall include a “Data availability” section. Provide here, if applicable, the accession numbers of data deposited in public repositories. Alternatively, indicate if all data derived from the research is included as supplementary information or available through a web page (provide the URL). 
  • Submissions must include a “Conflict of interest” (COI) declaration that discloses COI of any of the authors. Follow VMOA’s COI disclosure guidelines.
  • Include an “Author contributions” section describing the role of each author. Please, use the Contributor Roles Taxonomy (CRediT taxonomy) to describe each contribution.
  • Provide the names of the funding bodies and grant identification numbers in the "Funding Statement" section.
  • For research involving animals, the methods section must start with an "Ethical statement" section reporting an institutional committee approval of the experiment. It should also cite the guidelines and/or regulations that were followed to perform the experiment. VMOA strongly encourages authors to comply with the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines.
  • Plagiarism and attribution. Previous publications must be properly attributed, even if they were made by the same authors. Therefore, authors must clearly differentiate their ideas, concepts, and data, etc., from those from previous publications, and cite the corresponding references. In case of non-compliance, reviewers must report it to the editor.
  • Segmented publications are not accepted. Redundant or segmented publications (same hypothesis, methods, and results, but different text) pose a threat to publication ethics. Hence, we screen manuscripts in this regard and also ask reviewers to report any evidence of these practices. Failure to comply with this policy will result in manuscript rejection.
  • Supplemental material (text, tables, figures, etc.), if applicable, is combined in a single PDF file. Large data sets (*.xlsx), SVG (*.svg), and video (*.mp4) files may be uploaded separately. Do not include supplemental material in the main manuscript. Make sure all the information required to reproduce the experiment (i.e. accession numbers, primary data sets) is included in the main manuscript and not as supplementary information.

Every submission must be accompanied by a cover letter directed to the editor in chief. This letter must address the following points:

  1. Signed by the corresponding author on behalf of all authors,
  2. Contains a brief description of the study and its main contribution to science,
  3. A statement of manuscript originality, warranting it has not previously been published and it is not currently submitted to any other journal. Please, mention if results from the manuscript were presented at scientific congresses or are derived from a thesis dissertation that is held in a university public repository,
  4. It must mention if the manuscript has been rejected previously by another journal on the basis of either scope or scientific grounds.
  5. It must indicate that all authors qualify for authorship (refer to recommendations of the International Committee of Medical Journal Editors: http://www.icmje.org, have agreed to the submission, and that no authors have been omitted.